Revolution Acceleration Acquisition Corp and Berkshire Grey to Hold Virtual Investor Day on Tuesday, July 13 at 1 p.m. ET

NEXT STORY
Catalyst Pharmaceuticals Appoints Pharmaceutical Executive Molly Harper to its Board of Directors
PREV STORY
CicloMed Announces Initiation of Phase 1B Trial of Fosciclopirox in Newly Diagnosed and Recurrent Urothelial Cancer Patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

NeRRe Therapeutics announces positive findings from Phase 2b study with orvepitant in chronic cough

author_avatar
NASDAQ Market News

Sorrento Announces the Discovery of Salicyn-30 Small Molecule That Strongly Inhibits SARS-CoV-2 Infection in Preclinical Studies and Highlights its Place in a Potential Multi-Modal Therapy Strategy in Combination With Neutralizing Antibodies Against COVID-19

author_avatar
NASDAQ Market News

Tyme Announces Positive Efficacy Data for SM-88 in Pancreatic Cancer at 2018 ASCO Gastrointestinal Cancers Symposium

40 percent of evaluable patients achieved survival of more than 12 months, 30 percent ...

author_avatar
NASDAQ Market News